CVS Digestive Relief 48 Chewable Tablets Drug Facts

Manufacturer
CVS
Effective date
2026-08-13
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
daily-update
Hydrated at
2026-08-18 02:02:21

Label at a glance#

ProductCVS Stomach Relief
Active ingredientBISMUTH SUBSALICYLATE
Label structure8 sections

Dosage and administration

• chew or dissolve tablets in mouth. Do not swallow tablets whole. • adults and children 12 years and older: 2 tablets (1 dose) every 1/2 hour or 4 tablets (2 dose) every hour as needed for diarrhea • 2 tablets (1 dose) every 1/2 hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea) • do not exceed 8 doses (16 tablets) in 24 hours • use until diarrhea stops but not more than 2 days • ch...

Storage and handling

• each tablets contains: salicylate 102 mg • store at room temperature • avoid excessive heat

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Bismuth subsalicylate 262 mg

Purpose

OTC - PURPOSE SECTION

Upset stomach reliever and anti-diarrheal

Uses

INDICATIONS & USAGE SECTION

relieves

  • traveler’s diarrhea
  • diarrhea
  • upset stomach due to overindulgence in food and drink including
  • heartburn
  • indigestion
  • nausea
  • gas
  • belching
  • fullness

Warnings

WARNINGS SECTION

Reye's syndrome

SPL UNCLASSIFIED SECTION

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert:

SPL UNCLASSIFIED SECTION

Contains salicylate. Do not take if you are

  • allergic to salicylates (including aspirin)
  • taking other salicylate products

OTC - DO NOT USE SECTION

Do not use if you have

  • bloody or black stool
  • an ulcer
  • a bleeding problem

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • fever
  • mucus in the stool

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor before use if you are taking any drug for

  • anticoagulation (thinning of the blood)
  • diabetes
  • gout
  • arthritis

OTC - WHEN USING SECTION

When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • symptoms get worse or last more than 2 days
  • ringing in the ears occurs or loss of hearing occurs
  • diarrhea lasts more than 2 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.1-800-222-1222.

Directions

DOSAGE & ADMINISTRATION SECTION

  • chew or dissolve tablets in mouth. Do not swallow tablets whole.
  • adults and children 12 years and older: 2 tablets (1 dose) every 1/2 hour or 4 tablets (2 dose) every hour as needed for diarrhea
  • 2 tablets (1 dose) every 1/2 hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)
  • do not exceed 8 doses (16 tablets) in 24 hours
  • use until diarrhea stops but not more than 2 days
  • children under 12 years: ask a doctor
  • drink plenty of clear fluids to help prevent dehydration caused by diarrhea

Other information

STORAGE AND HANDLING SECTION

  • each tablets contains: salicylate 102 mg
  • store at room temperature
  • avoid excessive heat

Inactive ingredients

INACTIVE INGREDIENT SECTION

D&C Red# 27 lake, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol, sucralose.

Questions or comments?

OTC - QUESTIONS SECTION

1-866-467-2748

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 51316-124-48

Compare to active ingredient in Pepto-Bismol® Chewables*

Stomach Relief

Chewable tablets

Bismuth subsalicylate, Upset Stomach Reliever / Antidiarrheal

5- symptom digestive relief

  • Upset stomach,
  • Nausea,
  • Heartburn,
  • Indigestion,
  • Diarrhea
  • Original flavor

48 chewable tablets

TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR IF STRIP UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

Dist.by

*This product is not manufactured or distributed by Procter & Gamble Inc., the distributor of PEPTO-BISMOL® Chewables.

CVS stomach relief bismuth subsalicylate
CVS stomach relief bismuth subsalicylate

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15Product name120240313
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51316-12451316-124-48

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
52025-12-08full-release2026-06-01 01:20:45

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CVS Stomach ReliefBISMUTH SUBSALICYLATECVSeb96b2bb-7b2a-4664-96ac-73c917c84c302026-08-13WarningsExact identifier
ndc (package): 51316-124-48
ndc (product): 51316-124
ndc11 (package): 51316012448
spl id: dd70a0bf-28ad-4e16-a584-1694827a097f
spl set id: eb96b2bb-7b2a-4664-96ac-73c917c84c30

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.